Business
Celltrion's STEQEYMA® (ustekinumab-stba), now added to the Costco Member Prescription Program
Celltrion, Inc., today announced that STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) has been added to the Costco Member Prescription Program.
About this update from Celltrion, Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"STEQEYMA® (ustekinumab-stba) is Celltrion's biosimilar to STELARA® (ustekinumab), which was launched on March 12, 2025","length":122,"tagName":"p"}]},{"val":[{"type":"text","content":"Celltrion's adalimumab-aaty was previously added to the Costco Member Prescription Program in August 2024","length":109,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":231,"olType":false},{"type":"text","content":"JERSEY CITY, N.J., March 27, 2025 /PRNewswire/ -- Celltrion, Inc., today announced that STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) has been added to the Costco Member Prescription Program.","length":214,"tagName":"p"},{"type":"image","alt":"Celltrion CI (PRNewsfoto/Celltrion)","displaySize":"","headline":null,"caption":"Celltrion CI (PRNewsfoto/Celltrion)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/29f7024eb6887049478f3166bdb174c0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/zhv97G9Xy8993_Mur..7KQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/29f7024eb6887049478f3166bdb174c0","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2315627/Celltrion_CI_500px_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""We're focused on improving affordability and access to a widely used, high-cost treatment for a variety of inflammatory conditions," said Francine Galante, Vice President of Market Access at Celltrion USA. "The addition of STEQEYMA to the Costco Member Prescription Program together with adalimumab-aaty will help us deliver our commitment to lowering financial barriers and improving access to critical treatments."","length":451,"tagName":"p"},{"type":"text","content":"STEQEYMA is available in both subcutaneous injection and intravenous infusion and is indicated for the treatment of plaque psoriasis (PsO) and psoriatic arthritis (PsA) in adult and pediatric patients, as well as Crohn's disease (CD) and ulcerative colitis (UC) in adult patients.","length":289,"tagName":"p"},{"type":"text","content":"The Costco Member Prescription Program is a prescription drug discount card program offered by Costco Health Solutions that provides...